Premenstrual Syndrome Treatment Market Size & Trends Report by Type (Prescription, OTC), Product Type (Single Nutritional Supplement, Combined Nutritional Supplement), Drug Type (Analgesics, Antidepressants) & Regional Forecasts to 2030
The global premenstrual syndrome treatment market is expected to grow at a CAGR of around 5% during the forecast period. This growth is driven by increasing awareness of PMS and the rising number of individuals seeking treatment for associated symptoms. The expanding availability of over-the-counter solutions and prescription drugs is contributing to market growth. Innovations in therapy delivery methods and personalized treatment options are expected to fuel further market expansion. To learn more about the research report, download a sample report.
Report Overview
The premenstrual syndrome (PMS) treatment market refers to the sector that deals with medical products, therapies, and interventions aimed at managing and alleviating symptoms of PMS; a condition experienced by individuals of reproductive age. This market includes medications like antidepressants, hormonal therapies, and over-the-counter products that address the emotional, physical, and behavioural symptoms of PMS. PMS treatments also involve lifestyle interventions such as diet adjustments and exercise plans to improve symptoms.
To learn more about the research report, download a sample report.
Growing Awareness and Diagnosis: A Key Driver for Market Growth
The growing awareness and diagnosis of PMS are the most significant factors driving the market demand. As understanding of the condition increases, more individuals are recognizing the symptoms and seeking professional help. This has led to a rise in consultations and, consequently, an increased demand for PMS treatments. Improved diagnostic tools and education have made healthcare providers more capable of addressing PMS effectively, promoting the availability of various treatment options tailored to individual needs. Additionally, social media and online platforms have become instrumental in spreading information about PMS, helping individuals recognize and discuss their symptoms more openly, which further drives market demand for treatments.
To learn more about the research report, download a sample report.
Rising Preference for Natural and Herbal Remedies in PMS Management
One of the notable advancements shaping the premenstrual syndrome treatment market is the growing preference for natural and herbal remedies. Many individuals prefer natural alternatives to prescription medications due to concerns over side effects or the desire for more holistic treatment approaches. Herbal supplements like chasteberry, magnesium, and evening primrose oil have gained significant traction as PMS treatments. The growing acceptance of these remedies is supported by ongoing research highlighting their potential benefits in alleviating PMS symptoms. This trend aligns with the increasing consumer preference for plant-based, non-pharmaceutical solutions, which are seen as safer and more sustainable, further expanding the market. Additionally, wellness trends promoting overall lifestyle changes, such as improved nutrition and exercise, complement this shift toward more natural PMS management strategies.
Competitive Landscape Analysis
The global premenstrual syndrome treatment market is marked by the presence of established and emerging market players such as Herbalife International of America, Inc.; Pharmavite LLC; Nature’s Bounty; Amway; GNC Holdings, Inc.; USANA Health Sciences, Inc.; GlaxoSmithKline Plc; RBK Nutraceuticals Pty Ltd.; Archer Daniels Midland; Power Gummies; Looni and DM Pharma among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
|
Report Scope |
Details |
|
Base Year Considered |
2024 |
|
Historical Data |
2023 - 2024 |
|
Forecast Period |
2025 – 2030 |
|
Growth Rate |
5% |
|
Market Drivers |
|
|
Attractive Opportunities |
|
|
Segment Scope |
Type, Product, Drug Type, & Distribution Channel |
|
Regional Scope |
|
|
Key Companies Mapped |
Herbalife International of America, Inc.; Pharmavite LLC; Nature’s Bounty; Amway; GNC Holdings, Inc.; USANA Health Sciences, Inc.; GlaxoSmithKline Plc; RBK Nutraceuticals Pty Ltd.; Archer Daniels Midland; Power Gummies; Looni and DM Pharma among others |
|
Report Highlights |
Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Market Segmentation
This report by Medi-Tech Insights provides the size of the global premenstrual syndrome treatment market at the regional- and country-level from 2023 to 2030. The report further segments the market based on type, product, drug type, and distribution channel.
- Market Size & Forecast (2023-2030), By Type, USD Million
- Prescription
- OTC
- Market Size & Forecast (2023-2030), By Product, USD Million
- Single Nutritional Supplements
- Vitamins
- Minerals
- Herbal Supplements
- Others
- Combined Nutritional Supplements
- Single Nutritional Supplements
- Market Size & Forecast (2023-2030), By Drug Type, USD Million
- Analgesics
- Antidepressant
- Pain Relievers
- Oral Contraceptives
- Others
- Market Size & Forecast (2023-2030), By Distribution Channel, USD Million
- Online Sales Channel
- Direct Sales Channel
- Pharmacies / Drug Stores
- Other Channels
- Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Key Strategic Questions Addressed
- What is the market size & forecast of the premenstrual syndrome treatment market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the premenstrual syndrome treatment market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Â
- Introduction
- Introduction​
- Market Scope​
- Market Definition​
- Segments Covered​
- Regional Segmentation​
- Research Timeframe​
- Currency Considered​
- Study Limitations​
- Stakeholders​
- List of Abbreviations​
- Key Conferences and Events (2025-2026)​
- Research Methodology​
- Secondary Research​
- Primary Research​
- Market Estimation​
- Bottom-Up Approach​
- Top-Down Approach​
- Market Forecasting​
- Executive Summary
- Premenstrual Syndrome Treatment Market Snapshot (2025-2030)​
- Segment Overview​
- Regional Snapshot​
- Competitive Insights ​
- Market Overview
- Market Dynamics
- Drivers
- Increasing awareness and diagnosis of PMS symptoms
- Rising prevalence of PMS in the reproductive-age population
- Improved diagnostic tools, including hormone tests and symptom-tracking apps
- Increasing demand for non-invasive and over-the-counter treatments
- Growing integration of telemedicine services for accessible care
- Restraints​
- Limited awareness in low-income and rural regions
- High cost of advanced hormonal therapies and branded medications
- Potential side effects associated with certain treatments
- Opportunities​
- Growing acceptance of natural and herbal remedies in mainstream healthcare
- Development of personalized and targeted therapies for PMS management
- Key Market Trends​
- Adoption of digital health platforms for symptom tracking and personalized care
- Increasing popularity of herbal supplements like chasteberry and magnesium
- Unmet Market Needs​
- Industry Speaks​
- Global Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Type, USD Million
- Introduction​
- Prescription
- OTC
- Global Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Product, USD Million
- Introduction​
- Single Nutritional Supplements
- Vitamins
- Minerals
- Herbal Supplements
- Others
- Combined Nutritional Supplements
- Global Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Drug Type, USD Million
- Introduction​
- Analgesics
- Antidepressant
- Pain Relievers
- Oral Contraceptives
- Others
- Global Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Distribution Channel, USD Million
- Introduction​
- Online Sales Channel
- Direct Sales Channel
- Pharmacies / Drug Stores
- Other Channels
- Global Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction​
- North America Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Country, USD Million​
- US​
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Drug Type (USD Million)​
- Market Size & Forecast, By Distribution Channel (USD Million)​​
- Canada​
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Drug Type (USD Million)​
- Market Size & Forecast, By Distribution Channel (USD Million)​​
- US​
- Europe Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Country, USD Million​
- UK ​
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Drug Type (USD Million)​
- Market Size & Forecast, By Distribution Channel (USD Million)​​
- Germany ​
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Drug Type (USD Million)​
- Market Size & Forecast, By Distribution Channel (USD Million)​​
- Italy ​
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Drug Type (USD Million)​
- Market Size & Forecast, By Distribution Channel (USD Million)​​​​
- Spain ​
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Drug Type (USD Million)​
- Market Size & Forecast, By Distribution Channel (USD Million)​​
- Rest of Europe ​
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Drug Type (USD Million)​
- Market Size & Forecast, By Distribution Channel (USD Million)​​
- UK ​
- Asia Pacific (APAC) Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Country, USD Million​
- China ​
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Drug Type (USD Million)​
- Market Size & Forecast, By Distribution Channel (USD Million)​​
- Japan ​
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Drug Type (USD Million)​
- Market Size & Forecast, By Distribution Channel (USD Million)​​
- India ​
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Drug Type (USD Million)​
- Market Size & Forecast, By Distribution Channel (USD Million)​​
- Rest of Asia Pacific ​
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Drug Type (USD Million)​
- Market Size & Forecast, By Distribution Channel (USD Million)​​
- China ​
- Latin America (LATAM) Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), USD Million​
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Drug Type (USD Million)​
- Market Size & Forecast, By Distribution Channel (USD Million)​​
- Middle East & Africa (MEA) Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), USD Million​
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Drug Type (USD Million)​
- Market Size & Forecast, By Distribution Channel (USD Million)​​
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2024)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Herbalife International of America, Inc.
- Pharmavite LLC
- Nature’s Bounty
- Amway
- GNC Holdings, Inc.
- USANA Health Sciences, Inc.
- GlaxoSmithKline Plc
- RBK Nutraceuticals Pty Ltd.
- Archer Daniels Midland
- Power Gummies
- Looni
- Other Prominent Players
  Note: *Indicative list
 **For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Hospitals, Specialty Centers and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
